Small pharmaceutical firms to be shaken by new GMP policy

Small- and medium-sized companies are worried about financial pinch due to planned implementation of a new current good manufacturing practice (cGMP) system and validation from next year.

Last year, the Food and Drug Administration (KFDA) announced the new cGMP regulations by phase in a bid to upgrade its GMP level to that of advanced countries by referring to WHO and ICH guidelines.

For ...